Capital Research Global Investors Has $143.36 Million Stake in Exelon Corporation $EXC

Capital Research Global Investors increased its stake in shares of Exelon Corporation (NASDAQ:EXCFree Report) by 0.6% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 3,288,892 shares of the company’s stock after acquiring an additional 20,553 shares during the period. Capital Research Global Investors’ holdings in Exelon were worth $143,363,000 as of its most recent filing with the SEC.

A number of other hedge funds have also made changes to their positions in the stock. Plimoth Trust Co. LLC increased its holdings in shares of Exelon by 1.8% during the 4th quarter. Plimoth Trust Co. LLC now owns 13,055 shares of the company’s stock valued at $569,000 after acquiring an additional 230 shares during the last quarter. Verdence Capital Advisors LLC increased its holdings in shares of Exelon by 2.8% during the 4th quarter. Verdence Capital Advisors LLC now owns 8,634 shares of the company’s stock valued at $376,000 after acquiring an additional 233 shares during the last quarter. Axxcess Wealth Management LLC increased its holdings in shares of Exelon by 2.2% during the 3rd quarter. Axxcess Wealth Management LLC now owns 11,058 shares of the company’s stock valued at $498,000 after acquiring an additional 240 shares during the last quarter. Seeds Investor LLC boosted its stake in Exelon by 2.6% during the 4th quarter. Seeds Investor LLC now owns 9,536 shares of the company’s stock valued at $416,000 after purchasing an additional 241 shares during the period. Finally, HighPoint Advisor Group LLC boosted its stake in Exelon by 0.3% during the 4th quarter. HighPoint Advisor Group LLC now owns 82,907 shares of the company’s stock valued at $3,614,000 after purchasing an additional 242 shares during the period. Institutional investors and hedge funds own 80.92% of the company’s stock.

Exelon Price Performance

Shares of EXC stock opened at $44.80 on Tuesday. The stock has a 50 day moving average of $46.45 and a two-hundred day moving average of $45.98. The company has a current ratio of 0.94, a quick ratio of 0.85 and a debt-to-equity ratio of 1.65. Exelon Corporation has a 12 month low of $42.11 and a 12 month high of $50.65. The company has a market capitalization of $45.84 billion, a P/E ratio of 16.41, a P/E/G ratio of 2.65 and a beta of 0.31.

Exelon (NASDAQ:EXCGet Free Report) last announced its quarterly earnings data on Wednesday, May 6th. The company reported $0.91 EPS for the quarter, topping analysts’ consensus estimates of $0.88 by $0.03. Exelon had a return on equity of 9.83% and a net margin of 11.21%.The company had revenue of $7.24 billion during the quarter, compared to the consensus estimate of $6.93 billion. During the same quarter last year, the company earned $0.92 EPS. The company’s quarterly revenue was up 7.9% on a year-over-year basis. Exelon has set its FY 2026 guidance at 2.810-2.910 EPS. As a group, equities analysts expect that Exelon Corporation will post 2.86 EPS for the current year.

Exelon Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, June 15th. Shareholders of record on Thursday, June 4th will be given a $0.42 dividend. The ex-dividend date is Thursday, June 4th. This represents a $1.68 dividend on an annualized basis and a dividend yield of 3.8%. Exelon’s dividend payout ratio (DPR) is currently 61.54%.

Analyst Ratings Changes

Several brokerages recently weighed in on EXC. Wells Fargo & Company set a $50.00 target price on Exelon in a research note on Tuesday, April 21st. KeyCorp decreased their target price on Exelon from $43.00 to $41.00 and set an “underweight” rating for the company in a research note on Wednesday, May 13th. Wall Street Zen upgraded Exelon from a “sell” rating to a “hold” rating in a research note on Sunday, February 22nd. UBS Group increased their target price on Exelon from $48.00 to $51.00 and gave the company a “neutral” rating in a research note on Friday, February 20th. Finally, BMO Capital Markets restated a “market perform” rating and set a $49.00 target price (down from $52.00) on shares of Exelon in a research note on Friday, April 17th. Four equities research analysts have rated the stock with a Buy rating, thirteen have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $50.27.

Read Our Latest Stock Analysis on EXC

Exelon Company Profile

(Free Report)

Exelon Corporation (NASDAQ: EXC) is a Chicago-based energy company that operates primarily as a regulated electric and natural gas utility holding company. The company’s businesses focus on the delivery of electricity and related services to residential, commercial and industrial customers, as well as investments in grid modernization, customer energy solutions and demand-side programs. Exelon’s operations emphasize reliable service delivery, infrastructure maintenance and regulatory compliance across its utility footprint.

Formed in 2000 through the merger of Unicom and PECO Energy, Exelon historically combined generation and regulated utility businesses.

Further Reading

Want to see what other hedge funds are holding EXC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exelon Corporation (NASDAQ:EXCFree Report).

Institutional Ownership by Quarter for Exelon (NASDAQ:EXC)

Receive News & Ratings for Exelon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exelon and related companies with MarketBeat.com's FREE daily email newsletter.